Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00587847 · ClinicalTrials.gov registry record · NA
Campath Maintenance in Chronic Lymphocytic Leukemia
A NA study, sponsored by Northwell Health.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT00587847 is a NA study that was terminated before completion, run by Northwell Health. The registered enrollment target is 12 participants.
The verdict
NCT00587847, a NA study, was terminated before completion, sponsored by Northwell Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
This is a study designed to test whether giving campath (also known as alemtuzumab) on a maintenance schedule will prolong the time until the patient requires chemotherapy.
Interventions
- DRUG Campath
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2005-08 |
| Est. Completion | 2009-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00587847
The ClinicalTrials.gov registry entry for NCT00587847 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Campath is the first listed.
NCT00587847 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00587847 about?
NCT00587847 is a clinical study titled "Campath Maintenance in Chronic Lymphocytic Leukemia". This is a study designed to test whether giving campath (also known as alemtuzumab) on a maintenance schedule will prolong the time until the patient requires chemotherapy.
What is the current status of trial NCT00587847?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2005-08. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00587847?
The interventions under investigation include: Campath (DRUG).
Who is sponsoring clinical trial NCT00587847?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.